OSH Announces Appointment of Jim Fairbairn and Carole Staveley to the Board of Directors
Toronto, Ontario, Canada – May 10, 2016: Open Source Health Inc. (CSE:OSH), (Frankfurt:0OS), a cloud based precision medicine platform that puts control into the hands of women to educate, advocate and collaborate on their own healthcare is pleased to announce that Mr. James Fairbairn and Carole Staveley have been appointed to the Board of Directors of the Company.
The page you were looking for could not be found.
Check the URL for errors.“I am delighted to have Mr. Fairbairn and Ms. Staveley join the Board of OSH to provide their expert guidance as we enter the growth stage and launch the myAva platform in Atlanta,” says Sonya Satveit, CEO of Open Source Health Inc.
OSH has granted each Director 25,000 stock options as part of the standard board compensation approved by the shareholders.
OSH would also like to thank Mr. Mike Volker for his services to the Board of Directors and accepts his resignation effective immediately.
About Mr. James Fairbairn:
Mr. Fairbairn graduated from the University of Western Ontario and received his Chartered Accountant designation in 1987. He received his Institute Certified Director Designation (ICD.D) in 2009. Mr. Fairbairn has worked as a consultant almost exclusively in the resource and technology industry and has served as a senior officer and/or director and Chairman of the audit committees of a number of public and private companies.
About Ms. Carole Staveley:
Ms. Staveley is President of Inner Victory Coaching, an organization she founded to empower others to become their own Health Champions and reach their full potential. Inspired by the possibility of helping others to shorten their suffering time and reach their full potential, Ms. Staveley authored two books. Her latest one, Conquer Your Pain in 9 Steps (Influence Publishing 2015), takes you through her proven 9-step Health Champion approach to suffering less and achieving more. Ms. Staveley’s background as a leader in the health field includes 20 years of management experience in the pharmaceutical industry. She holds a B.Sc. in Biochemistry from McMaster University and a Masters in Business Administration from York University’s Schulich School of Business.
About Open Source Health Inc.:
Open Source Health takes a truly patient-centered approach and is in the business of providing a real-time integrative healthcare solution for women in an open source architecture. Open Source Health Inc. is leading the digital transformation of integrative and preventative health by leveraging the latest trends in digital health, personalized health, social health and participatory medicine.
For more information, visit www.opensourcehealth.com
For further information, please contact Investor Relations at Open Source Health Inc.
Toll Free: 1.866.403.1933 in North America
International Calling: +01.647.872.9986
Forward Looking Statements
Certain information set forth in this news release may contain forward-looking statements that involve substantial known and unknown risks and uncertainties. These forward-looking statements are subject to numerous risks and uncertainties, certain of which are beyond the control of Open Source Health Inc. (“OSH”), including, but not limited to, the impact of general economic conditions, industry conditions and the uncertainty of obtaining additional financing. Readers are cautioned that the assumptions used in the preparation of such information, although considered reasonable at the time of preparation, may prove to be imprecise and, as such, undue reliance should not be placed on forward-looking statements. Forward-looking statements contained in this press release are expressly qualified by this cautionary statement.
The forward-looking statements contained in this press release are made as of the date of this press release, and OSH does not undertake any obligation to update publicly or to revise any of the included forward-looking statements, whether as a result of new information, future events or otherwise, except as expressly required by applicable securities law.